Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides
Cancer remains a major global health challenge. Immunotherapy has revolutionized the management of cancer, yet only a limited number of patients respond to such treatments. This is largely attributed to the immunosuppressive tumor microenvironment, which diminishes the effectiveness of immunotherapy...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2024-12-01
|
| Serija: | Human Vaccines & Immunotherapeutics |
| Teme: | |
| Online pristup: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2385654 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
